Diagnos IncOTCQB:DGNOFView on Canadian Exchange
- LAST PRICE0.1858
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close--- / 0.1858
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | DGNOF |
|---|---|---|
| 10:40 ET | 7700 | 0.18 |
| 10:42 ET | 12000 | 0.1762 |
| 02:43 ET | 500 | 0.1858 |
Nov 12, 2024
DIAGNOS Announces Cross-listing of its Common Shares on the Frankfurt Stock Exchange, from 9:00AM ET on Tuesday Nov 12, 2024 by Dow Jones
9:00AM ET on Tuesday Nov 12, 2024 by Dow Jones
Oct 25, 2024
DIAGNOS Announces Closing of Private Placement, from 3:45PM ET on Friday Oct 25, 2024 by Dow Jones
3:45PM ET on Friday Oct 25, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Diagnos Inc | 25.7M | --- | --- |
Company Information
Diagnos Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. It provides software-based services to assist health specialists in the detection of diabetic retinopathy and other eye-related pathologies. Its geographical areas include Canada, the United States of America, Mexico, and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.
Contact Information
- Headquarters
- 7005 Taschereau Blvd Suite 340BROSSARD, QC, Canada J4Z 1A7
- Phone
- 450-678-8882
- Fax
- 450-678-8882
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $25.7M |
|---|---|
Revenue (TTM) | $163.5K |
Shares Outstanding | 95.1M |
Diagnos Inc does not pay a dividend. | |
Beta | -0.56 |
EPS | $-0.04 |
Book Value | $-0.04 |
P/E Ratio | --- |
Price/Sales (TTM) | 157.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,555.95% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
